Table of Contents
The future of three-dimensional bioprinting (3DBP) and its transformation of the healthcare sector will be determined by the breadth and depth of its application potential, and its ability to unleash a whole new world of application segments. From printing a tissue or cells to developing human organs, 3DBP has shown its technology capability in the world of prototyping. 3DBP has a very optimistic scenario and its impact in the future is expected to profoundly affect multiple industries.
The research service offers insights on the following:
•Current status of the healthcare sector: In this section, the major shifts in the healthcare sector in terms of technologies or products have been captured.
•Transformation Assessment of 3DBP in the healthcare sector: The role of 3DBP in the transformation of each of the shifts in the healthcare sector has been assessed individually.
•The various business perspectives: An insight into the different business perspectives with respect to 3DBP in the healthcare sector has been provided.
•Strategic Perspectives: Based on the various assessments carried out, strategic insights into various factors such as entry barriers for this novel technology and the impact of regulations, the innovation eco system, and the marketing strategies have been provided.
What are the Big Shifts Expected in the Healthcare Sector by 2020?
Technological advancements have revolutionized the healthcare sector. Evolution of new technologies that are compact yet powerful, inexpensive yet effective, has encouraged researchers to develop novel technologies for various applications in the healthcare sector. These advancements have helped the healthcare sector in meeting market needs. Bioprinting can drive advancements in the healthcare field, for example, by advancing tissue engineering and biomaterials (which are used to print 3D objects).
Some of the major transformations or innovations in the healthcare sector are developing from the convergence of different technologies. Such convergence is seen to have a major impact in terms of meeting the needs in the healthcare sector.
- Mind-machine interface (MMI), alternately referred to as direct neural interface (DNI) or brain-computer interface (BCI), is a direct communication channel between the brain and an artificial device, which may either be an external or an implanted device.
- BCI enables bi-directional communication between the brain and the device, implying that either the brain can control the device or the device can control/monitor the brain.
- BCI devices are used to monitor, aid, enhance, repair, and control the neural pathway or are controlled by the human cognitive and/or sensory-motor systems.
- The fundamental feature of an MMI device is its ability to tap into brain signals. Once the BCI interface has been established, opportunities open up to either record signals or to use the signals to manipulate the user or the MMI device.
- By establishing a direct and bi-directional communication pathway, MMI devices can either circumvent or bypass broken neural pathways, which may result from accidents, disease, and so on.
- MMI devices can either be invasive (implanted into the gray matter to enable continuous and wireless pathways), partially invasive or non-invasive (wearable devices such as headsets, helmets).
- Traditional MMI applications include brain activity mapping, communication, and physical rehabilitation. Recently, gaming, entertainment, cognitive training and education, and military applications have become sought-after applications.
- The evolution of the MMI from a clinical concept to a valuable diagnostic, therapeutic, and consumer application tool is a result of collaboration between diverse fields such as sensor technology, neuroscience, computer science, and wireless communications.
- Initial commercialization is expected in the medium term (2016 to 2018) and wide-scale adoption is expected in the long term (2019 to 2020)
Continuous Patient Monitoring (CPM)
- Continuous patient monitoring (CPM) refers to round-the-clock and remote monitoring of patients in order to oversee recovery, vital signs, or overall well-being of a person.
- CPM as a technology overlaps with remote patient monitoring (RPM) and point-of-care testing (POC) in developing solutions for patient monitoring.
- CPM leverages advances and innovations in sensor technology, software, miniaturization, and wireless communications in enabling diagnosis, consulting, monitoring, treatment, and education of remote patients and consumers.
- CPM allows healthcare providers, caregivers, and family members to monitor patients round the clock and in less time, without geographic constraints.
- CPM and RPM enable over-the-air diagnosis, and thus save time and cost in travel. This feature is of particular interest in present fast-paced world and brings convenience to the elderly, recovering patients, and patients without easy access to healthcare.
- As patients are becoming more involved in their health management, all the stakeholders in the value chain can extend their reach and effectiveness to patients at a location of their convenience.
- CPM is a vital technology platform as it caters to a significant patient population—the elderly and the chronically ill, especially since their numbers are projected to rise in the coming years.
- Minimizes healthcare costs along the value chain by minimizing the need for hospital visits, enabling remote diagnosis and consultation, and easier and more flexible integration into clinical workflow and electronic health records.
- CPM technologies and devices are poised for high growth; a number of CPM devices have already been commercialized successfully and widespread adoption is expected by 2018.
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...
Digital transformation helps enterprises improve operational performance, efficiency, and business process. It involves the utilization of digital technologies, such as mobility, analytics, and social ...
The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...